{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:26:28Z","timestamp":1791293188594,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T00:00:00Z","timestamp":1492128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"NIH","award":["4T32HD040127-15"],"award-info":[{"award-number":["4T32HD040127-15"]}]},{"name":"Rett Syndrome Research Trust"},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NCI","award":["2P30CA016086-40"],"award-info":[{"award-number":["2P30CA016086-40"]}]},{"name":"NINDS Center","award":["P30 NS045892"],"award-info":[{"award-number":["P30 NS045892"]}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.omtm.2017.04.006","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T05:15:15Z","timestamp":1492578915000},"page":"106-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"C","title":["Improved MECP2 Gene Therapy Extends the Survival of MeCP2-Null Mice without Apparent Toxicity after Intracisternal Delivery"],"prefix":"10.1016","volume":"5","author":[{"given":"Sarah E.","family":"Sinnett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph D.","family":"Hector","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal K.E.","family":"Gadalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Heindel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Zaric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.S.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart R.","family":"Cobb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2017.04.006_bib1","doi-asserted-by":"crossref","DOI":"10.2217\/fnl.12.79","article-title":"Recent progress in Rett syndrome and MeCP2 dysfunction: assessment of potential treatment options","volume":"8","author":"Chapleau","year":"2013","journal-title":"Future Neurol."},{"key":"10.1016\/j.omtm.2017.04.006_bib2","doi-asserted-by":"crossref","first-page":"6154080","DOI":"10.1155\/2016\/6154080","article-title":"Developmental dynamics of Rett syndrome","volume":"2016","author":"Feldman","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.omtm.2017.04.006_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jpeds.2009.07.015","article-title":"Longevity in Rett syndrome: analysis of the North American Database","volume":"156","author":"Kirby","year":"2010","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.omtm.2017.04.006_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2017.04.006_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/11.2.115","article-title":"Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation","volume":"11","author":"Shahbazian","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2017.04.006_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrg3897","article-title":"Rett syndrome: a complex disorder with simple roots","volume":"16","author":"Lyst","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtm.2017.04.006_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/978-3-642-45106-5_18","article-title":"Brain-derived neurotrophic factor and Rett syndrome","volume":"220","author":"Katz","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.omtm.2017.04.006_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neubiorev.2014.01.011","article-title":"Rett syndrome and the urge of novel approaches to study MeCP2 functions and mechanisms of action","volume":"46","author":"Bedogni","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.omtm.2017.04.006_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2350-8-36","article-title":"Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets","volume":"8","author":"Jordan","year":"2007","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.omtm.2017.04.006_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nbd.2013.08.001","article-title":"Loss of MeCP2 function is associated with distinct gene expression changes in the striatum","volume":"59","author":"Zhao","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtm.2017.04.006_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/mt.2012.200","article-title":"Improved survival and reduced phenotypic severity following AAV9\/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice","volume":"21","author":"Gadalla","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2017.04.006_bib12","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.1523\/JNEUROSCI.1854-13.2013","article-title":"Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome","volume":"33","author":"Garg","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtm.2017.04.006_bib13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/gt.2012.101","article-title":"Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates","volume":"20","author":"Gray","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2017.04.006_bib14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors","volume":"22","author":"Gray","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2017.04.006_bib15","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.omtm.2017.04.006_bib16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/85906","article-title":"Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice","volume":"27","author":"Chen","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2017.04.006_bib17","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1111\/nmo.12057","article-title":"Visualization of spinal afferent innervation in the mouse colon by AAV8-mediated GFP expression","volume":"25","author":"Schuster","year":"2013","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.omtm.2017.04.006_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ajpath.2013.03.019","article-title":"Mild overexpression of Mecp2 in mice causes a higher susceptibility toward seizures","volume":"183","author":"Bodda","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2017.04.006_bib19","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","article-title":"Mild overexpression of MeCP2 causes a progressive neurological disorder in mice","volume":"13","author":"Collins","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2017.04.006_bib20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nn.2997","article-title":"Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses","volume":"15","author":"Goffin","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtm.2017.04.006_bib21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/npp.2012.116","article-title":"The impact of MeCP2 loss- or gain-of-function on synaptic plasticity","volume":"38","author":"Na","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.omtm.2017.04.006_bib22","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/brain\/aws096","article-title":"Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome","volume":"135","author":"Robinson","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.omtm.2017.04.006_bib23","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/hmg\/ddl099","article-title":"Identification of cis-regulatory elements for MECP2 expression","volume":"15","author":"Liu","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2017.04.006_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/2040-2392-4-46","article-title":"Decitabine alters the expression of Mecp2 isoforms via dynamic DNA methylation at the Mecp2 regulatory elements in neural stem cells","volume":"4","author":"Liyanage","year":"2013","journal-title":"Mol. Autism"},{"key":"10.1016\/j.omtm.2017.04.006_bib25","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/nn2010","article-title":"Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA","volume":"10","author":"Klein","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtm.2017.04.006_bib26","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1523\/JNEUROSCI.0600-12.2013","article-title":"Comprehensive expression analyses of neural cell-type-specific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes","volume":"33","author":"Jovi\u010di\u0107","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtm.2017.04.006_bib27","doi-asserted-by":"crossref","first-page":"e88685","DOI":"10.1371\/journal.pone.0088685","article-title":"Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22","volume":"9","author":"Feng","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2017.04.006_bib28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.fob.2015.08.010","article-title":"MicroRNAs downregulated in neuropathic pain regulate MeCP2 and BDNF related to pain sensitivity","volume":"5","author":"Manners","year":"2015","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.omtm.2017.04.006_bib29","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/ATVBAHA.114.305212","article-title":"MicroRNA-22 regulates smooth muscle cell differentiation from stem cells by targeting methyl CpG-binding protein 2","volume":"35","author":"Zhao","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.omtm.2017.04.006_bib30","doi-asserted-by":"crossref","first-page":"20392","DOI":"10.1038\/srep20392","article-title":"Reciprocal regulation of autism-related genes MeCP2 and PTEN via microRNAs","volume":"6","author":"Lyu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2017.04.006_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.omtm.2017.04.007","article-title":"Development of a novel AAV gene therapy cassette with improved safety features and efficacy in a mouse model of Rett syndrome","volume":"5","author":"Gadalla","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2017.04.006_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2016.12.009","article-title":"A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome","volume":"99","author":"Matagne","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtm.2017.04.006_bib33","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/nar\/gkh349","article-title":"The major form of MeCP2 has a novel N-terminus generated by alternative splicing","volume":"32","author":"Kriaucionis","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2017.04.006_bib34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4161\/rna.7.3.11564","article-title":"Alternative polyadenylation of MeCP2: influence of cis-acting elements and trans-acting factors","volume":"7","author":"Newnham","year":"2010","journal-title":"RNA Biol."},{"key":"10.1016\/j.omtm.2017.04.006_bib35","doi-asserted-by":"crossref","first-page":"16002","DOI":"10.1038\/mtm.2016.2","article-title":"Manufacturing of recombinant adeno-associated viral vectors for clinical trials","volume":"3","author":"Cl\u00e9ment","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2017.04.006_bib36","doi-asserted-by":"crossref","first-page":"4.17.1","DOI":"10.1002\/0471142301.ns0417s57","article-title":"Production of recombinant adeno-associated viral vectors and use in in\u00a0vitro and in\u00a0vivo administration","volume":"57","author":"Gray","year":"2011","journal-title":"Curr. Protoc. Neurosci."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905011730061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905011730061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T03:46:12Z","timestamp":1569037572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S232905011730061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":36,"alternative-id":["S232905011730061X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2017.04.006","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727607094.793544060","asserted-by":"object"}]},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved MECP2 Gene Therapy Extends the Survival of MeCP2-Null Mice without Apparent Toxicity after Intracisternal Delivery","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2017.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors.","name":"copyright","label":"Copyright"}]}}